4.7 Article

Whole-genome landscape of adult T-cell leukemia/lymphoma

期刊

BLOOD
卷 139, 期 7, 页码 967-982

出版社

AMER SOC HEMATOLOGY

关键词

-

资金

  1. NationalCancer Institute, National Institutes of Health (NIH), US Department of Health and Human Services
  2. Japan Society for the Promotion of Science KAKENHI [JP21H04809, JP21H05051]
  3. Japan Agency for Medical Research and Development [JP21ck0106538, JP19ck0106254, JP19ak0101064]
  4. Japan Society for the Promotion of Science [JP18H04907]
  5. Japan Science and Technology Agency Moonshot RD Program [JPMJMS2022]
  6. Daiichi Sankyo Foundation of Life Science
  7. Takeda Science Foundation
  8. Japanese Society of Hematology Research Grant
  9. National Institutes of Health National Cancer Institute Cancer Center Support Grant [P30 CA008748]
  10. Albert Einstein Cancer Center

向作者/读者索取更多资源

Through whole-genome sequencing of 150 ATL cases, we identified the genetic landscape of ATL. We found frequent loss-of-function alterations in the CIC gene, which were previously overlooked. Truncations of the REL gene were also common and found in diffuse large B-cell lymphoma. Recurrent mutations in non-coding regions of driver genes were identified. By combining analyses of coding and noncoding mutations, structural variations, and copy number alterations, we discovered 56 recurrently altered driver genes, including 11 novel ones. ATL cases were classified into 2 molecular groups based on their driver alteration profile.
Adult T-cell leukemia/lymphoma (ATL) is an aggressive neoplasm immunophenotypically resembling regulatory T cells, associated with human T-cell leukemia virus type-1. Here, we performed whole-genome sequencing (WGS) of 150 ATL cases to reveal the overarching landscape of genetic alterations in ATL. We discovered frequent (33%) loss-of-function alterations preferentially targeting the CIC long isoform, which were overlooked by previous exome-centric studies of various cancer types. Long but not short isoform-specific inactivation of Cic selectively increased CD4(+)CD25(+)Foxp3(+) T cells in vivo. We also found recurrent (13%) 39-truncations of REL, which induce transcriptional upregulation and generate gain-of-function proteins. More importantly, REL truncations are also common in diffuse large B-cell lymphoma, especially in germinal center B-cell-like subtype (12%). In the non-coding genome, we identified recurrent mutations in regulatory elements, particularly splice sites, of several driver genes. In addition, we characterized the different mutational processes operative in clustered hypermutation sites within and outside immunoglobulin/T-cell receptor genes and identified the mutational enrichment at the binding sites of host and viral transcription factors, suggesting their activities in ATL. By combining the analyses for coding and noncoding mutations, structural variations, and copy number alterations, we discovered 56 recurrently altered driver genes, including 11 novel ones. Finally, ATL cases were classified into 2 molecular groups with distinct clinical and genetic characteristics based on the driver alteration profile. Our findings not only help to improve diagnostic and therapeutic strategies in ATL, but also provide insights into T-cell biology and have implications for genome-wide cancer driver discovery.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据